# Encision Inc > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Encision Inc). ## Overview Encision Inc. designs and sells Active Electrode Monitoring (AEM) surgical instruments and related products that are intended to reduce the risk of stray electrosurgical energy during minimally invasive surgery. The company also offers disposable and multi-use laparoscopic scissors, monitors, and related accessories, and it supports adoption through direct sales, independent distributors, and hospital education efforts. ## Products & services • Active Electrode Monitoring (AEM) surgical instruments • AEM monitors and related accessories • enTouch disposable laparoscopic scissors • AEM 2X enTouch reusable scissors • Proof-of-concept services for robotic surgery applications - **AEM surgical instruments** (55%) — Monopolar surgical instruments designed to monitor and reduce stray electrosurgical energy risk. - **Scissors and cutting instruments** (30%) — Disposable and multi-use laparoscopic scissors sold for hot and cold dissection. - **Monitors and accessories** (10%) — Monitoring devices and related accessories that support the AEM product ecosystem. - **Services and development work** (5%) — Proof-of-concept and technical services tied to robotic and minimally invasive surgery. - Active Electrode Monitoring (AEM) instruments for laparoscopic surgery - AEM monitors and accessories used with monitored electrosurgery - enTouch disposable laparoscopic scissors - AEM 2X enTouch multi-use scissors with thermochromic tracking - Technical education and sales support for hospital adoption - Proof-of-concept services for robotic-assisted minimally invasive surgery ## Customers Encision sells primarily to hospitals, surgeons, and healthcare systems that perform minimally invasive and laparoscopic procedures. Adoption is driven by patient-safety concerns, clinical education, and hospital purchasing channels such as GPOs, integrated delivery networks, and the U.S. Veterans Affairs system. - **Hospitals and surgical centers** (primary) — Buy AEM instruments, scissors, and monitors to reduce electrosurgical injury risk and improve OR workflow. - **Group Purchasing Organizations (GPOs)** (primary) — Contract for broader hospital access and help standardize adoption across member facilities. - **Integrated delivery networks and hospital systems** (primary) — Purchase through system-wide sourcing agreements to standardize surgical products across facilities. - **Veterans Affairs medical centers** (secondary) — Use the company’s patient-safety technology in a large U.S. healthcare network. - **International distributors** (secondary) — Market products in Australia, New Zealand, and selected European markets where CE marking enables sales. - Hospitals buying AEM tools to improve patient safety in surgery - Surgeons and OR teams that prefer monitored electrosurgical instruments - GPOs and hospital systems that standardize surgical supply contracts - Integrated delivery networks seeking lower-risk laparoscopic tools - Veterans Affairs medical centers using approved proprietary technology - Distributors in export markets that market the product line locally ## Geography The company is headquartered in the United States and most of its business is focused on U.S. hospitals and surgical networks. International sales are still small, but it has distributors in Australia and New Zealand and CE marking allows access to Europe as distribution channels develop. - United States is the core market and main source of commercial activity - Australia and New Zealand are served through independent distributors - CE marking opens Europe, but the channel is still developing - U.S. hospital systems and VA facilities are key domestic access points - International revenue is small relative to domestic sales ## Strategy Encision’s strategy is to broaden adoption of AEM technology by educating hospitals and surgeons about electrosurgical injury risk and by expanding its sales network. It is also trying to deepen access through GPOs, hospital systems, and distributors while using product innovation such as the 2X Scissors to widen use cases and improve value perception. - **Broaden U.S. hospital adoption** (short-term) — The company needs more operating-room penetration to drive recurring product sales. - **Increase awareness of AEM patient-safety benefits** (short-term) — Demand depends on convincing clinicians and hospitals that monitored electrosurgery reduces risk. - **Extend product usage with 2X Scissors** (medium-term) — A lower-cost multi-use device can open new use segments and standardize customers on the portfolio. - **Build international distribution** (medium-term) — CE marking and overseas distributors create incremental market opportunities beyond the U.S. - Expand hospital awareness of AEM technology through clinical education - Use independent representatives to reach more operating rooms - Secure supplier agreements with GPOs and hospital systems - Grow international sales through distributors and CE-marked products - Use 2X Scissors to broaden the addressable laparoscopic scissor market - Support robotic-surgery applications through proof-of-concept work ## Risks Encision’s business depends on convincing hospitals and surgeons to adopt a niche safety technology, so market acceptance and long sales cycles are central risks. It also faces supply-chain concentration, intense competition from larger electrosurgical manufacturers, regulatory oversight, cybersecurity exposure, and quarterly volatility typical of a small medical-device company. - **Limited market acceptance of AEM technology** [high] — Demand depends on educating hospitals about electrosurgical hazards and proving clinical value. - **Supply chain concentration** [high] — The company relies on single-source suppliers and subcontractors for key components and assemblies. - **Competitive pressure from larger medical-device companies** [medium] — Rivals have greater financial, technical, and marketing resources and entrenched products. - **Regulatory compliance and approval risk** [high] — FDA and other agencies can inspect, restrict, or delay manufacturing and product approvals. - **Cybersecurity and data breach risk** [medium] — IT systems handle sensitive customer and employee information and could be disrupted or compromised. - Market adoption may stay slow if clinicians do not accept AEM benefits - Long sales cycles raise selling costs and delay revenue conversion - Single-source components and subcontractors can disrupt supply - Larger competitors have more resources and established channels - FDA and other regulatory requirements can delay or block product changes - Cybersecurity incidents could disrupt operations or damage trust ## Accounting Encision’s results are likely affected by revenue timing from product shipments and by quarter-to-quarter volatility tied to small order flow and adoption cycles. Investors should also watch inventory, warranty or return-related estimates, and any impairment risk if product lines or distribution channels underperform; the company’s small scale can make these judgments more visible in reported results. - **Revenue recognition timing** — Affects quarterly comparability and reported growth rates - **Inventory valuation and obsolescence** — Can affect gross margin and operating results - **Impairment of long-lived assets or intangibles** — Could create non-cash charges in weak periods - **Quarterly volatility and seasonality** — Makes trend analysis and guidance less predictable - Revenue timing may vary with hospital purchasing and shipment patterns - Quarterly results can swing with small changes in order volume - Inventory and obsolescence estimates matter for a narrow product line - Potential impairment risk exists if product adoption or channels weaken - Small-company cost structure can amplify the impact of accounting estimates --- *Last updated: 2026-04-28T20:03:05.558640+00:00*